CLS vs NXPI

Celestica Inc. exhibits a stark divergence between its explosive growth metrics and its deterministic health indicators, highlighted by a weak Piotroski F-Score of 3/9. While the company delivers exceptional revenue (43.6%) and earnings (77.7%) growth with a consistent track record of beats, the current price of $410.21 represents a massive premium over both the Graham Number ($55.82) and the growth-based Intrinsic Value ($211.81). The combination of bearish insider selling and a weak technical trend suggests the stock may be overextended despite strong analyst sentiment. Consequently, the valuation risk currently outweighs the growth momentum.

NXP Semiconductors trades at $197.10, down 10.3% over the past year amid sector-wide semiconductor volatility, yet exhibits strong fundamental resilience and superior profitability relative to peers. Despite near-term revenue contraction (-2.4% YoY), the company maintains best-in-class margins—gross margin of 55.4%, operating margin of 28.24%, and ROE of 20.87%—signaling pricing power and operational efficiency. Forward P/E of 15.08 appears compelling versus sector average P/E of 138.37 and an analyst target price of $258.43, implying 31% upside. Bullish sentiment is reinforced by consistent earnings beats over the last five years and a sustainable 2.06% dividend yield with a 50% payout ratio, though recent insider selling introduces mild caution.